Loss of Claudin-1 Expression Correlates with Malignancy of Hepatocellular Carcinoma

Journal of Surgical Research

Volumn 139, Issue 1, 2007, Pages 68-76

  Higashi, Yukihiro ^a   Suzuki, Shohachi ^a   Sakaguchi, Takanori ^a   Nakamura, Toshio ^a   Baba, Satoshi ^a   Reinecker, Hans Christian ^b   Nakamura, Satoshi ^a   Konno, Hiroyuki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

adherens junction; claudin; E cadherin; hepatectomy; hepatocellular carcinoma; tight junction

Indexed keywords

CLAUDIN 1; PROTEIN SUBUNIT; UVOMORULIN;

ADULT; AGED; ARTICLE; CANCER CELL; CANCER INVASION; CELL COUNT; CELL DIFFERENTIATION; DOWN REGULATION; EPITHELIUM CELL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; SCORING SYSTEM; SURVIVAL RATE; TISSUE SECTION;

ADULT; AGED; AGED, 80 AND OVER; CADHERINS; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LIVER; LIVER NEOPLASMS; MALE; MEMBRANE PROTEINS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; SURVIVAL RATE;

EID: 33947581841     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2006.08.038     Document Type: Article

References (37)

1. Takeichi M. Cadherin cell adhesion receptors as a morphogenetic regulator. Science 251 (1991) 1451
2. Tsukita S., and Furuse M. The structure and function of claudins, cell adhesion molecules at tight junctions. Ann NY Acad Sci 915 (2000) 129
3. Birchmeier C., Birchmeier W., Gherardi E., et al. Met, metastasis, motility and more. Nat Rev Mol Cell Biol 4 (2003) 915
4. Tsukita S., Furuse M., and Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2 (2001) 285
5. Madara J.L. Regulation of the movement of solutes across tight junctions. Annu Rev Physiol 60 (1998) 143
6. Anderson J.M., and Van Itallie C.M. Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269 (1995) G467
7. Tsukita S., and Furuse M. Occludin and claudins in tight-junction strands: leading or supporting players?. Trends Cell Biol 9 (1999) 268
8. Saitou M., Furuse M., Sasaki H., et al. Complex phenotype of mice lacking occludin, a component of tight junction strands. Mol Biol Cell 11 (2000) 4131
9. Furuse M., Fujita K., Hiiragi T., et al. Claudin-1 and -2: novel integral membrane proteins localizing at tight junctions with no sequence similarity to occludin. J Cell Biol 141 (1998) 1539
10. Rahner C., Mitic L.L., and Anderson J.M. Heterogeneity in expression and subcellular localization of claudins 2, 3, 4, and 5 in the rat liver, pancreas, and gut. Gastroenterology 120 (2001) 411
11. Furuse M., Hata M., Furuse K., et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 156 (2002) 1099
12. Tsukita S., and Furuse M. Claudin-based barrier in simple and stratified cellular sheets. Curr Opin Cell Biol 14 (2002) 531
13. Resnick M.B., Konkin T., Routhier J., et al. Claudin-1 is a strong prognostic indicator in stage II colonic cancer: a tissue microarray study. Mod Pathol 18 (2005) 511
14. Hoevel T., Macek R., Swisshelm K., et al. Reexpression of the TJ protein CLDN1 induces apoptosis in breast tumor spheroids. Int J Cancer 108 (2004) 374
15. Kominsky S.L., Argani P., Korz D., et al. Loss of the tight junction protein claudin-7 correlates with histological grade in both ductal carcinoma in situ and invasive ductal carcinoma of the breast. Oncogene 22 (2003) 2021
16. Miwa N., Furuse M., Tsukita S., et al. Involvement of claudin-1 in the beta-catenin/Tcf signaling pathway and its frequent upregulation in human colorectal cancers. Oncol Res 12 (2000) 469
17. Shiozaki H., Tahara H., Oka H., et al. Expression of immunoreactive E-cadherin adhesion molecules in human cancers. Am J Pathol 139 (1991) 17
18. Shimoyama Y., Hirohashi S., Hirano S., et al. Cadherin cell-adhesion molecules in human epithelial tissues and carcinomas. Cancer Res 49 (1989) 2128
19. Frixen U.H., Behrens J., Sachs M., et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113 (1991) 173
20. Endo K., Ueda T., Ueyama J., et al. Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients' survival. Hum Pathol 31 (2000) 558
21. Osada T., Sakamoto M., Ino Y., et al. E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24 (1996) 1460
22. Dorudi S., Sheffield J.P., Poulsom R., et al. E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study. Am J Pathol 142 (1993) 981
23. Mayer B., Johnson J.P., Leitl F., et al. E-cadherin expression in primary and metastatic gastric cancer: down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res 53 (1993) 1690
24. Moller C.J., Christgau S., Williamson M.R., et al. Differential expression of neural cell adhesion molecule and cadherins in pancreatic islets, glucagonomas, and insulinomas. Mol Endocrinol 6 (1992) 1332
25. Ihara A., Koizumi H., Hashizume R., et al. Expression of epithelial cadherin and alpha- and beta-catenins in nontumoral livers and hepatocellular carcinomas. Hepatology 23 (1996) 1441
26. Japan, LCSGo. General rules for the clinical and pathological study of primary liver cancer. (ed 4) (2000), Kanehara Press, Tokyo, Japan
27. Nagao T., Inoue S., Yoshimi F., et al. Postoperative recurrence of hepatocellular carcinoma. Ann Surg 211 (1990) 28
28. Fukuda S., Itamoto T., Nakahara H., et al. Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma. Hepatogastroenterology 52 (2005) 1163
29. Sakaguchi T., Gu X., Golden H.M., et al. Cloning of the human claudin-2 5′-flanking region revealed a TATA-less promoter with conserved binding sites in mouse and human for caudal-related homeodomain proteins and hepatocyte nuclear factor-1alpha. J Biol Chem 277 (2002) 21361
30. Nuruki K., Toyoyama H., Ueno S., et al. E-cadherin but not N-cadherin expression is correlated with the intracellular distribution of catenins in human hepatocellular carcinomas. Oncol Rep 5 (1998) 1109
31. Chen Y., Lu Q., Schneeberger E.E., et al. Restoration of tight junction structure and barrier function by down-regulation of the mitogen-activated protein kinase pathway in ras-transformed Madin-Darby canine kidney cells. Mol Biol Cell 11 (2000) 849
32. Zavadil J., and Bottinger E.P. TGF-beta and epithelial-to-mesenchymal transitions. Oncogene 24 (2005) 5764
33. Oft M., Heider K.H., and Beug H. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis. Curr Biol 8 (1998) 1243
34. Ozdamar B., Bose R., Barrios-Rodiles M., et al. Regulation of the polarity protein Par6 by TGFbeta receptors controls epithelial cell plasticity. Science 307 (2005) 1603
35. Gao L., Joberty G., and Macara I.G. Assembly of epithelial tight junctions is negatively regulated by Par6. Curr Biol 12 (2002) 221
36. Michl P., Buchholz M., Rolke M., et al. Claudin-4: a new target for pancreatic cancer treatment using Clostridium perfringens enterotoxin. Gastroenterology 121 (2001) 678
37. de Oliveira S.S., de Oliveira I.M., De Souza W., et al. Claudins upregulation in human colorectal cancer. FEBS Lett 579 (2005) 6179